Hydralazine Hydrochloride 68475-0514-02
- Manufacturer
- Navinta Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 25, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA202938
Need to source Hydralazine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydralazine Hydrochloride | 20 mg/mL |
Drug Class
Arteriolar Vasodilation [PE]Arteriolar Vasodilator [EPC]
Selected Package
68475-0514-02Selected25 VIAL in 1 PACKAGE (68475-514-02) / 1 mL in 1 VIAL (68475-514-01)